Literature DB >> 18776918

Post-injury baicalein improves histological and functional outcomes and reduces inflammatory cytokines after experimental traumatic brain injury.

S-F Chen1, C-W Hsu, W-H Huang, J-Y Wang.   

Abstract

BACKGROUND AND
PURPOSE: Traumatic brain injury (TBI) triggers a complex series of inflammatory responses that contribute to secondary tissue damage. The aim of this study was to investigate the effect of baicalein, a flavonoid possessing potent anti-inflammatory properties, on functional and histological outcomes and inflammatory cytokine expression, following TBI in rats. EXPERIMENTAL APPROACH: Rats subjected to controlled cortical impact injury were injected with baicalein (30 mg kg(-1)) or vehicle immediately after injury or daily for 4 days. Neurological status was evaluated using the rotarod, adhesive removal, modified neurological severity scores and beam walk tests. Contusion volume and neuronal degeneration were measured using cresyl violet and FluoroJade B (FJB) histochemistry. Levels of tumour necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta) and interleukin-6 (IL-6) mRNA and protein were assessed by real-time quantitative reverse transcriptase-PCR, enzyme-linked immunosorbent assay and immunohistochemistry. KEY
RESULTS: Single-dose and multiple-dose treatment with baicalein significantly improved functional recovery and reduced contusion volumes up to day 28 post-injury, although multiple-dose baicalein was the more effective treatment. Single-dose baicalein also significantly reduced the number of degenerating neurons (31%) on post-injury day 1 as indicated by FJB staining. These changes were associated with significantly decreased levels, at the contusion site, of TNF-alpha, IL-1 beta and IL-6 mRNA at 6 h, and cytokine protein on day 1 post-injury. CONCLUSIONS AND IMPLICATIONS: Post-injury treatment with baicalein improved functional and histological outcomes and reduced induction of proinflammatory cytokines in rat TBI. The neuroprotective effect of baicalein may be related to a decreased inflammatory response following the injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18776918      PMCID: PMC2607198          DOI: 10.1038/bjp.2008.345

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  64 in total

1.  Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration.

Authors:  L C Schmued; K J Hopkins
Journal:  Brain Res       Date:  2000-08-25       Impact factor: 3.252

2.  Endothelial cell activation following moderate traumatic brain injury.

Authors:  R Balabanov; H Goldman; S Murphy; G Pellizon; C Owen; J Rafols; P Dore-Duffy
Journal:  Neurol Res       Date:  2001 Mar-Apr       Impact factor: 2.448

3.  IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function.

Authors:  E Csuka; M C Morganti-Kossmann; P M Lenzlinger; H Joller; O Trentz; T Kossmann
Journal:  J Neuroimmunol       Date:  1999-11-15       Impact factor: 3.478

4.  Effects of baicalein isolated from Scutellaria baicalensis Radix on adhesion molecule expression induced by thrombin and thrombin receptor agonist peptide in cultured human umbilical vein endothelial cells.

Authors:  Y Kimura; N Matsushita; K Yokoi-Hayashi; H Okuda
Journal:  Planta Med       Date:  2001-06       Impact factor: 3.352

5.  Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms.

Authors:  K Ishige; D Schubert; Y Sagara
Journal:  Free Radic Biol Med       Date:  2001-02-15       Impact factor: 7.376

Review 6.  Potential mechanisms of interleukin-1 involvement in cerebral ischaemia.

Authors:  O Touzani; H Boutin; J Chuquet; N Rothwell
Journal:  J Neuroimmunol       Date:  1999-12       Impact factor: 3.478

Review 7.  Cytokines and acute neurodegeneration.

Authors:  S M Allan; N J Rothwell
Journal:  Nat Rev Neurosci       Date:  2001-10       Impact factor: 34.870

8.  Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats.

Authors:  J Chen; Y Li; L Wang; Z Zhang; D Lu; M Lu; M Chopp
Journal:  Stroke       Date:  2001-04       Impact factor: 7.914

9.  Lovastatin improves histological and functional outcomes and reduces inflammation after experimental traumatic brain injury.

Authors:  Szu-Fu Chen; Tai-Ho Hung; Chien-Cheng Chen; Kuei-Han Lin; Ya-Ni Huang; Hung-Chih Tsai; Jia-Yi Wang
Journal:  Life Sci       Date:  2007-06-13       Impact factor: 5.037

10.  Protective effects of flavonoids in the roots of Scutellaria baicalensis Georgi against hydrogen peroxide-induced oxidative stress in HS-SY5Y cells.

Authors:  Z Gao; K Huang; H Xu
Journal:  Pharmacol Res       Date:  2001-02       Impact factor: 10.334

View more
  54 in total

Review 1.  Vitamins and nutrients as primary treatments in experimental brain injury: Clinical implications for nutraceutical therapies.

Authors:  Cole Vonder Haar; Todd C Peterson; Kris M Martens; Michael R Hoane
Journal:  Brain Res       Date:  2015-12-23       Impact factor: 3.252

2.  Effects of ketamine on endotoxin and traumatic brain injury induced cytokine production in the rat.

Authors:  Jeremy L Ward; Matthew T Harting; Charles S Cox; David W Mercer
Journal:  J Trauma       Date:  2011-06

3.  Sensorimotor behavioral tests for use in a juvenile rat model of traumatic brain injury: assessment of sex differences.

Authors:  Kristin L Russell; Katrina M Kutchko; Stephen C Fowler; Nancy E J Berman; Beth Levant
Journal:  J Neurosci Methods       Date:  2011-05-11       Impact factor: 2.390

4.  Post-trauma administration of the pifithrin-α oxygen analog improves histological and functional outcomes after experimental traumatic brain injury.

Authors:  L-Y Yang; Y-H Chu; D Tweedie; Q-S Yu; C G Pick; B J Hoffer; N H Greig; J-Y Wang
Journal:  Exp Neurol       Date:  2015-03-24       Impact factor: 5.330

5.  Neuroprotective effect of Pycnogenol® following traumatic brain injury.

Authors:  Stephen W Scheff; Mubeen A Ansari; Kelly N Roberts
Journal:  Exp Neurol       Date:  2012-10-08       Impact factor: 5.330

6.  The flavonoid Baicalein attenuates cuprizone-induced demyelination via suppression of neuroinflammation.

Authors:  Miho Hashimoto; Shinji Yamamoto; Kensuke Iwasa; Kota Yamashina; Masaki Ishikawa; Kei Maruyama; Francesca Bosetti; Keisuke Yoshikawa
Journal:  Brain Res Bull       Date:  2017-09-15       Impact factor: 4.077

Review 7.  Natural Compounds as a Therapeutic Intervention following Traumatic Brain Injury: The Role of Phytochemicals.

Authors:  Stephen W Scheff; Mubeen A Ansari
Journal:  J Neurotrauma       Date:  2016-12-21       Impact factor: 5.269

8.  Inhibition of Peripheral TNF-α and Downregulation of Microglial Activation by Alpha-Lipoic Acid and Etanercept Protect Rat Brain Against Ischemic Stroke.

Authors:  Ming-Hsiu Wu; Chao-Ching Huang; Chung-Ching Chio; Kuen-Jer Tsai; Ching-Ping Chang; Nan-Kai Lin; Mao-Tsun Lin
Journal:  Mol Neurobiol       Date:  2015-09-15       Impact factor: 5.590

9.  Manganese and ammonia interactions in the brain of cirrhotic rats: effects on brain ammonia metabolism.

Authors:  Susana Rivera-Mancía; Camilo Ríos; Sergio Montes
Journal:  Neurochem Res       Date:  2012-05       Impact factor: 3.996

10.  Therapeutic efficacy of Neuro AiD™ (MLC 601), a traditional Chinese medicine, in experimental traumatic brain injury.

Authors:  Ming-Che Tsai; Ching-Ping Chang; Syue-Wei Peng; Kai-Sheng Jhuang; Yi-Hsien Fang; Mao-Tsun Lin; Thomas Chang-Yao Tsao
Journal:  J Neuroimmune Pharmacol       Date:  2014-10-21       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.